Position
Fidelity in Eikon Therapeutics, Inc.
Back to the book · All holders of EIKN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $9.48M$10.58 → $13.05
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q1 2026 | 3.84M | $40.6M | — | — | — | 0.0% |
| Q2 2026 | 4.99M | $65.2M | $13.05 | $9.48M | $15.1M | 0.0% |